Not known Details About XP-59
Lumacaftor and ivacaftor is utilised to treat selected varieties of cystic fibrosis (an inborn disease that triggers problems with respiratory, digestion, and copy) in adults and youngsters 1 12 months of age and older. Lumacaftor is in a class of remedies referred to as cystic fibrosis transmembrane conductance regulator (CFTR) correctors.Disclaim